InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Roberts M Scot, Directeur Scientifique. Officer active across 1 companies, notably Altimmune, Inc.. In total, 6 disclosures have been recorded. The latest transaction was filed on 29 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€13,5945,462 shares@ €2.48890.0025% mcap12.5% of flow
Common Stock, par value $0.0001
SEC:0001104659-22-076291:0·
€46,45425,583 shares@ €1.81580.0084% mcap42.8% of flow
Common Stock, par value $0.0001
SEC:0001104659-22-075361:0·
€12,9542,106 shares@ €6.15120.0023% mcap11.9% of flow
Common Stock, par value $0.0001
SEC:0001104659-22-011517:0·
€12,9542,106 shares@ €6.151253.3% of flow
Common Stock, par value $0.0001
SEC:0001104659-22-011517·
€11,3441,750 shares@ €6.482446.7% of flow
Common Stock, par value $0.0001
SEC:0001104659-21-101661·
€11,3441,750 shares@ €6.48240.0020% mcap10.4% of flow
Common Stock, par value $0.0001
SEC:0001104659-21-101661:0·
6 of 6 declarations
About Roberts M Scot
Scot Roberts is the Chief Scientific Officer at Altimmune, Inc. He is responsible for overseeing the company's research and development initiatives, ensuring innovation in the biotechnology field. With deep expertise, he plays a key role in advancing scientific projects and implementing new therapeutic solutions.
